Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.

Disease markers - 1 Jan 2019

Zhang Jie, Song Qianqian, Liu Jinxia, Lu Lina, Xu Yuqing, Zheng Wenjie

Abstract excerpt

Cyclin-dependent kinase regulatory subunit 2 (CKS2) is a member of the cell cycle-dependent protein kinase subunit family, which is implicated as an oncogene in various malignancies. However, the clinical significance, oncogenic functions, and related mechanisms of CKS2 in hepatocellular carcinoma (HCC) remain largely unclear. In the present study, expression features and prognostic value of CKS2 were evaluated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to CDC2-CDC28 Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Cycle Proteins

Share to Follow-Up Studies

Share to Liver Cirrhosis

Share to Liver Neoplasms

Share to Survival Rate

Share to Tumor Cells, Cultured

Source

Open in PubMed Open full text

Identifiers

PMID: 31781310
DOI: 10.1155/2019/8964015
PMCID: PMC6855053

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.PMID 31781310Read ↗

Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinomaSemantic proximity Read ↗

Oncogenic potential of Cyclin Kinase Subunit‐2 in cholangiocarcinomaSemantic proximity Read ↗

Biological functions and therapeutic potential of CKS2 in human cancerSemantic proximity Read ↗

CKS2 in human cancers: Clinical roles and current perspectives (Review)Semantic proximity Read ↗

CKS2 Predicts A Poor Prognosis and Contributes to Malignant Progression of Pancreatic CancerSemantic proximity Read ↗

High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for GliomaSemantic proximity Read ↗

The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cellsSemantic proximity Read ↗

Cyclin-dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial-mesenchymal transition-like process in glioma by activating TGFβ/SMAD signaling.Semantic proximity Read ↗

Uridine‐cytidine kinase 2 upregulation predicts poor prognosis of hepatocellular carcinoma and is associated with cancer aggressivenessSemantic proximity Read ↗

LASP2 is downregulated in human liver cancer and contributes to hepatoblastoma cell malignant phenotypes through MAPK/ERK pathway.Semantic proximity Read ↗

Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinomaSemantic proximity Read ↗

SOCS2 is a potential prognostic marker that suppresses the viability of hepatocellular carcinoma cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.